Literature DB >> 6301993

Nuclear antigen detected in hepatoma cell lines containing integrated hepatitis B virus DNA.

Y M Wen, K Mitamura, B Merchant, Z Y Tang, R H Purcell.   

Abstract

We identified, by anticomplement immunofluorescence, a nuclear antigen (hepatitis B virus-associated nuclear antigen [HBNA]) in two human hepatoma cell lines containing integrated hepatitis B virus DNA but not in three hepatoma cell lines lacking it. The antigen resembled neoantigens associated with the oncogenesis of certain papovaviruses, adenoviruses, and herpesviruses. Antibody to the antigen (anti-HBNA) was found in 7.3% of hepatitis B surface antigen-positive sera from patients with hepatocellular carcinoma but not in surface antigen-negative sera. The staining of HBNA was characterized by two patterns, reticular nuclear fluorescence and nucleolar fluorescence. The expression of HBNA did not parallel the production of extracellular hepatitis B surface antigen. Treatment of cells with proteinase K, RNase, DNase, or cycloheximide significantly diminished the staining of HBNA.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301993      PMCID: PMC348106          DOI: 10.1128/iai.39.3.1361-1367.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  THE NATURE AND LOCALIZATION OF THE SV 40-INDUCED COMPLEMENT-FIXING ANTIGEN.

Authors:  R V GILDEN; R I CARP; F TAGUCHI; V DEFEND
Journal:  Proc Natl Acad Sci U S A       Date:  1965-03       Impact factor: 11.205

2.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

3.  Co-occurrence of hepatitis B surface antigen of a particular subtype and antibody to a heterologous subtypic specificity in the same serum.

Authors:  T Sasaki; Y Ohkubo; Y Yamashita; M Imai; Y Miyakawa
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

4.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

5.  Biology of hepatitis B virus.

Authors:  P Tiollais; P Charnay; G N Vyas
Journal:  Science       Date:  1981-07-24       Impact factor: 47.728

6.  Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line.

Authors:  D P Aden; A Fogel; S Plotkin; I Damjanov; B B Knowles
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

7.  A nucleolar antigen found in a broad range of human malignant tumor specimens.

Authors:  H Busch; F Gyorkey; R K Busch; F M Davis; P Gyorkey; K Smetana
Journal:  Cancer Res       Date:  1979-08       Impact factor: 12.701

8.  Effects of cycloheximide and puromycin on synthesis of simian virus 40 T antigen in green monkey kidney cells.

Authors:  R V Gilden; R I Carp
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

9.  Detection of hepatitis B virus-specific DNA in the genomes of human hepatocellular carcinoma and liver cirrhosis tissues.

Authors:  R Koshy; P Maupas; R Müller; P H Hofschneider
Journal:  J Gen Virol       Date:  1981-11       Impact factor: 3.891

10.  Establishment of a continuously growing cell line from primary carcinoma of the liver.

Authors:  J J Alexander; E M Bey; E W Geddes; G Lecatsas
Journal:  S Afr Med J       Date:  1976-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.